Inspire Medical Systems Inc. falsely touted its preparations for launching a new sleep apnea device, customer demand for the product, and initial successes before reporting sluggish sales, an investor ...

Inspire Medical Systems, which produces an implant to treat sleep apnea, extended the run spots involving the Golden Bachelorette winner through the holidays.

Inspire Medical (NYSE: INSP) shares got a boost after hours today on third-quarter results that beat the consensus Wall ...

Today, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of City of Pontiac Reestablished General Employees' Retirement System against Inspire Medical Systems, Inc. ("Inspire Medical" or ...

Inspire Medical (($INSP)) announced an update on their ongoing clinical study. Inspire Medical Systems, Inc. has launched the Pediatric Down ...

Gross margin was 85.8% for the third quarter of 2025 compared to 84.1% in the third quarter of 2024. The year-over-year increase was due to higher sales volume and higher Inspire V sales mix, which ...

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” third-quarter 2025 investor letter. A copy ...

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Inspire Medical Systems, Inc. common stock between August 6, 2024 and ...

What Happened? Shares of medical technology company Inspire Medical Systems (NYSE:INSP) fell 3.4% in the afternoon session after Jefferies downgraded the stock to Hold from Buy and sharply reduced its ...

I love that Oura tells me gently how I can improve my bad sleep scores in truly tangible ways.” And if the price ... Sleep ...

Inspire (INSP) delivered earnings and revenue surprises of +353.33% and +1.61%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?